Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
Open Access
- 31 October 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10), e27230
- https://doi.org/10.1371/journal.pone.0027230
Abstract
Recent research implicates soluble aggregated forms of α-synuclein as neurotoxic species with a central role in the pathogenesis of Parkinson's disease and related disorders. The pathway by which α-synuclein aggregates is believed to follow a step-wise pattern, in which dimers and smaller oligomers are initially formed. Here, we used H4 neuroglioma cells expressing α-synuclein fused to hemi:GFP constructs to study the effects of α-synuclein monoclonal antibodies on the early stages of aggregation, as quantified by Bimolecular Fluorescence Complementation assay. Widefield and confocal microscopy revealed that cells treated for 48 h with monoclonal antibodies internalized antibodies to various degrees. C-terminal and oligomer-selective α-synuclein antibodies reduced the extent of α-synuclein dimerization/oligomerization, as indicated by decreased GFP fluorescence signal. Furthermore, ELISA measurements on lysates and conditioned media from antibody treated cells displayed lower α-synuclein levels compared to untreated cells, suggesting increased protein turnover. Taken together, our results propose that extracellular administration of monoclonal antibodies can modify or inhibit early steps in the aggregation process of α-synuclein, thus providing further support for passive immunization against diseases with α-synuclein pathology.Keywords
This publication has 32 references indexed in Scilit:
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body DiseasePLOS ONE, 2011
- Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation PathwayJournal of Neuroscience, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- α-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophyExperimental Neurology, 2003
- Visualization of Interactions among bZIP and Rel Family Proteins in Living Cells Using Bimolecular Fluorescence ComplementationMolecular Cell, 2002
- A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament AssemblyJournal of Biological Chemistry, 2001
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophyNeuroscience Letters, 1998
- α-Synuclein in Lewy bodiesNature, 1997
- Tumor size: effect on monoclonal antibody uptake in tumor models.1986